- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Eli Lilly & Co (LLY)
| Open: | 41.2400 | Day's Range: | 41.2100 - 41.5500 | Volume: | 4,191,492 | Bid: | 41.3200 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 41.1100 | 52wk Range: | 33.7500 - 42.0300 | 1-Yr Rtn: | +14.85% | Ask: | 41.4900 |
Key Statistics for LLY
| Current P/E Ratio (ttm) | 10.1724 |
|---|---|
| Estimated P/E (12/2012) | 12.6571 |
| Earnings Per Share (USD) (ttm) | 4.0600 |
| Est. EPS (USD) (12/2012) | 3.2630 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 47,925.15 |
| Shares Outstanding (M) | 1,160.42 |
| Enterprise Value (M USD) (ttm) | 48,402.85 |
| Enterprise Value/EBITDA (ttm) | 6.55 |
| Price/Book (mrq) | 3.2307 |
| Price/Sale (ttm) | 1.9149 |
| Dividend Indicated Gross Yield | 4.7435 |
| Next Earnings Announcement | 07/25/2012 |
More LLY Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for LLY
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for LLY
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company's products are sold in countries around the world. Eli Lilly's products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
| John C LechleiterChairman/President/CEO | Maria CrowePres:Manufacturing Operations |
| Derica W RiceExec VP:Global Svcs/CFO | Jan M LundbergExec VP:Science & Technology |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page